Should intermittent androgen deprivation be used in routine clinical practice?

MS Bhandari, J Crook, M Hussain - Journal of clinical oncology, 2005 - ascopubs.org
For several decades, androgen deprivation (AD) has been the mainstay for treating
metastatic prostate cancer. AD can be attained by a variety of means; however, irrespective …
被引用次数：81 相关文章

[引用][C] Should intermittent androgen deprivation be used in routine clinical practice?

MS BHANDARI, J CROOK… - Journal of clinical …, 2005 - pascal-francis.inist.fr
Should intermittent androgen deprivation be used in routine clinical practice? CNRS Inist
Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search Advanced …

Should intermittent androgen deprivation be used in routine clinical practice?

MS Bhandari, J Crook, M Hussain - Journal of Clinical Oncology …, 2005 - europepmc.org
For several decades, androgen deprivation (AD) has been the mainstay for treating
metastatic prostate cancer. AD can be attained by a variety of means; however, irrespective …

[引用][C] Should intermittent androgen deprivation be used in routine clinical practice?

B MS - J Clin Oncol, 2005 - cir.nii.ac.jp

Should intermittent androgen deprivation be used in routine clinical practice?

MS Bhandari, J Crook… - Journal of clinical …, 2005 - pubmed.ncbi.nlm.nih.gov
For several decades, androgen deprivation (AD) has been the mainstay for treating
metastatic prostate cancer. AD can be attained by a variety of means; however, irrespective …

Should intermittent androgen deprivation be used in routine clinical practice?

MS Bhandari, J Crook… - Journal of Clinical …, 2005 - scholars.northwestern.edu
For several decades, androgen deprivation (AD) has been the mainstay for treating
metastatic prostate cancer. AD can be attained by a variety of means; however, irrespective …